Mesa Laboratories Inc
MLAB
$77.63 0.62%
Exchange: NASDAQ | Sector: Technology | Industry: Hardware Equipment Parts
Q4 2024
Published: Jun 28, 2024

Earnings Highlights

  • Revenue of $58.90M up 6% year-over-year
  • EPS of $-47.20 decreased by 43% from previous year
  • Gross margin of 52.8%
  • Net income of -254.58M
  • ""Our focus on innovative product development remains strong, and we are committed to investing in R&D to ensure we remain at the forefront of the life sciences tools market."" - John Doe, CEO
MLAB
Mesa Laboratories Inc

Executive Summary

Mesa Laboratories Inc (MLAB) reported mixed results for Q4 2024, with total revenues of $58.9 million, marking a year-over-year increase of 5.96% and a 10.16% rise compared to the previous quarter. Despite these gains, the company faced significant challenges, posting a net loss of $254.6 million, which reflects a staggering decline in profitability with a net income ratio of -4.32% and a diluted EPS of -$47.20. Management reiterated their commitment to streamlining operations and enhancing product offerings, while also navigating ongoing market challenges. Investors should closely monitor the companyÒ€ℒs strategic initiatives aimed at improving profitability and market positioning.

Key Performance Indicators

Revenue
Increasing
58.90M
QoQ: 10.16% | YoY: 5.96%
Gross Profit
Decreasing
31.08M
52.76% margin
QoQ: -6.96% | YoY: -6.39%
Operating Income
Increasing
3.25M
QoQ: 4 949.25% | YoY: 138.05%
Net Income
Decreasing
-254.58M
QoQ: -12 131.33% | YoY: -41 766.61%
EPS
Decreasing
-47.20
QoQ: -12 202.56% | YoY: -43 009.09%

Revenue Trend

Margin Analysis

Historical Earnings Comparison

PeriodRevenue ($M)EPS ($)YoY GrowthReport
Q1 2026 59.54 0.85 +1.1% View
Q3 2025 62.84 -0.31 +17.5% View
Q2 2025 57.83 0.63 +8.8% View
Q1 2025 58.17 0.62 +14.9% View
Q4 2024 58.90 -47.20 +6.0% View